(Q53411447)

English

Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio- and immuno-resistant lung carcinoma cells.

scientific article published on 24 February 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio- and immuno-resistant lung carcinoma cells. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kenji Chamoto

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

Tsuguhide Takeshima

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

Daiko Wakita

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

Takayuki Ohkuri

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

Shigeru Ashino

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

Tokuhiko Omatsu

6

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

Hiroki Shirato

7

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

Hidemitsu Kitamura

8

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

Yuji Togashi

9

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

Takashi Nishimura

10

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

publication date

24 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

100

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

934-939

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

Organ motion in image-guided radiotherapy: lessons from real-time tumor-tracking radiotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Three-dimensional small-volume irradiation for residual or recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Head and neck cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Current developments in cancer vaccines and cellular immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

T-cell responses of vaccinated cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Immunosuppressive strategies that are mediated by tumor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Surmounting tumor-induced immune suppression by frequent vaccination or immunization in the absence of B cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

CpG oligodeoxynucleotide enhances tumor response to radiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

The critical role of Th1-dominant immunity in tumor immunology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

The critical role of type-1 innate and acquired immunity in tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Generation and targeting of human tumor-specific Tc1 and Th1 cells transduced with a lentivirus containing a chimeric immunoglobulin T-cell receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Peptide epitope identification for tumor-reactive CD4 T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Transforming growth factor beta: a promotor of late connective tissue injury following radiotherapy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Immune modulation by ionizing radiation and its implications for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

The Swedish Council on Technology Assessment in Health Care (SBU) Systematic Overview of Radiotherapy for Cancer including a Prospective Survey of Radiotherapy Practice in Sweden 2001--Summary and Conclusions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01114.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2009.01114.X

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19245434

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53411447&oldid=1506725434"